Nasdaq.com (US)
Alzamend Neuro, Inc. Receives SOW Termination Notice on November 11, 2026 Following FDA Feedback
Alzamend Neuro, Inc. announced that on November 11, 2026, The General Hospital Corporation d/b/a Massachusetts General Hospital terminated the statement of work for patients afflicted with bipolar disorder…